Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) is -50.52% lower on its value in year-to-date trading and has touched a low of $0.28 and a high of $2.47 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LXRX stock was last observed hovering at around $0.36 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.37, the stock is -13.38% and -42.04% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.65 million and changing 0.61% at the moment leaves the stock -71.67% off its SMA200. LXRX registered -85.02% loss for a year compared to 6-month loss of -77.72%. The firm has a 50-day simple moving average (SMA 50) of $0.631 and a 200-day simple moving average (SMA200) of $1.29095.
The stock witnessed a -48.54% gain in the last 1 month and extending the period to 3 months gives it a -46.04%, and is -4.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.40% over the week and 13.04% over the month.
Lexicon Pharmaceuticals Inc (LXRX) has around 103 employees, a market worth around $132.09M and $31.08M in sales. Profit margin for the company is -644.78%. Distance from 52-week low is 28.84% and -85.21% from its 52-week high. The company has generated returns on investments over the last 12 months (-79.89%).
with sales reaching $1.26M over the same period.The EPS is expected to grow by 41.27% this year, but quarterly earnings will post -72.33% year-over-year. Quarterly sales are estimated to grow 11.73% in year-over-year returns.
Lexicon Pharmaceuticals Inc (LXRX) Top Institutional Holders
168.0 institutions hold shares in Lexicon Pharmaceuticals Inc (LXRX), with institutional investors hold 85.13% of the company’s shares. The shares outstanding are 361.49M, and float is at 179.54M with Short Float at 26.43%. Institutions hold 84.11% of the Float.
The top institutional shareholder in the company is ARTAL GROUP S.A. with over 175.1 million shares valued at $294.17 million. The investor’s holdings represent 56.3318% of the LXRX Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 38.69 million shares valued at $$64.99 million to account for 15.7656 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 9.89 million shares representing 4.0304% and valued at over $16.62 million, while VANGUARD GROUP INC holds 3.1277 of the shares totaling 7.68 million with a market value of $12.89 million.
Lexicon Pharmaceuticals Inc (LXRX) Insider Activity
#####
